SMTL ID : 4bcp.2 (1 other biounit)

Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

hetero-oligomer

Ligands

1 x T3C: 2-[[3-(1,4-DIAZEPAN-1-YL)PHENYL]AMINO]-4-[4-METHYL-2-(METHYLAMINO)-1,3-THIAZOL-5-YL]PYRIMIDINE-5-CARBONITRILE(Non-covalent)

T3C.1: 17 residues within 4Å: Chain A: I.12, V.20, A.33, K.35, V.66, F.82, E.83, F.84, L.85, H.86, Q.87, D.88, K.91, Q.133, N.134, L.136, D.147 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.20, A:F.82, A:L.136 Hydrogen bonds: A:L.85, A:L.85, A:D.147, A:D.147

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain B: K.32, Q.33, L.73, S.74, S.75, M.76, S.77 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:K.32, B:S.75

1 x SGM: MONOTHIOGLYCEROL(Non-covalent)

SGM.3: 6 residues within 4Å: Chain B: M.19, K.22, C.23, R.71, D.135, A.138 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:K.22

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shao, H. et al., Substituted 4-(Thiazol-5-Yl)-2-(Phenylamino)Pyrimidines are Highly Active Cdk9 Inhibitors: Synthesis, X-Ray Crystal Structure, Sar and Anti-Cancer Activities. J.Med.Chem. (2013)

Release Date

2013-04-17

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence